Abstract
Background
Sentinel lymph node (SLN) mapping has been recently introduced to the field of gastric cancer. To the best of our knowledge, no study has dealt with the accuracy of SLN mapping according to the T stage of the primary tumor. The aim of the present study was to evaluate SLN status according to the T stage of the primary tumors.
Methods
Eighty patients with gastric cancer underwent SLN mapping with patent blue dye during gastric resection.
Results
Forty-seven patients underwent distal subtotal gastrectomy; 17 patients, proximal gastrectomy; 14, total gastrectomy; and 2, gastric stump resection. SLNs were stained in 61/80 patients (76.3%). The number of stained SLNs varied from 1 to 16 (mean, 3.3). Patients undergoing proximal gastrectomy had a mean of 3 stained SLNs, whereas patients undergoing distal subtotal gastrectomy had a mean of 2.8 stained SLNs. In 55/61 patients (90.2%) with stained SLNs a positive correlation was found between the presence of metastases and stained or non-stained SLNs. Ten out of 11 patients (90.9%) with T1 tumors (mean, 3.27 SLNs per patient) and 15/17 patients with T2 tumors (88.2%; mean, 3 SLNs per patient) had stained SLNs as compared to only 33/48 (68.8%) of patients with T3 tumors (mean, 3.3 SLNs per patient). The positive predictive value of the SLN mapping was 100%, the negative predictive value was 76.9%, and sensitivity was 85.4%.
Conclusion
While in T1 and T2 tumors sentinel node mapping may be of assistance in the decision-making process regarding the extent of lymphadenectomy (sensitivity, 100%; negative predictive value, 90%-100%), SLN mapping in patients with T3 tumors will be misleading in a third of the patients and should not be attempted.
Article PDF
Similar content being viewed by others
References
Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–466.
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–399.
Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (≥5 cm) invasive breast cancer. Ann Surg Oncol 2001;8:688–692.
Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645–653.
Medina-Franco H, Beenken SW, Heslin MJ, Urist MM. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol 2001;8:716–719.
Reintgen D, Balch CM, Kirkwood J, Ross M. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997;225:1–14.
Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, et al. The role of sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000;80:1799–1809.
Thorn M. Lymphatic mapping and sentinel node biopsy: is the method applicable to patients with colorectal and gastric cancer? Eur J Surg 2000;166:755–758.
Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8:150–157.
Kim MC, Kim HH, Jung GJ, Lee JH, Choi SR, Kang DY, et al. Lymphatic mapping and sentinel node biopsy using 99mTC tin colloid in gastric cancer. Ann Surg 2004;239:383–387.
Song X, Wang L, Chen W, Pan T, Zhu H, Xu J, et al. Lymphatic mapping and sentinel node biopsy in gastric cancer. Am J Surg 2004;187:270–273.
Nimura H, Narimiya N, Mitsumori N, Yamazaki Y, Yanaga K, Urashima M. Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes of patients with gastric cancer. Br J Surg 2004;91:575–579.
Pacelli F. Lymph node staging. 4th International Gastric Cancer Congress, New York, April 29–May 2, 2001. Abstract #S 27:325.
Aikou T, Higashi H, Natsugoe S, Hokita S, Baba M, Tako S. Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann Surg Oncol 2001;9(Suppl):90S–93S.
Catarci M, Guadagni S, Zaraca F, Pistoia MA, Mastracchio A, Trecca A, et al. Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer. Ann Surg Oncol 1998;5:580–584.
Miwa K. Optimal nodal dissection for early gastric cancer. Nippon Geka Gakkai Zasshi 2001;102:484–489.
Nimura H, Kashimura H, Sano Y, Aoki T, Fujisaki J, Narimiya N, et al. Sentinel node navigation using an infrared electronic endoscope, and the possibility of expanding indications for gastrectomy preserving the hepatic and celiac branches of the vagus nerve. 4th International Gastric Cancer Congress, New York, April 29–May 2, 2001. Abstract # 547:594.
Osaka H, Yashiro M, Sawada T, Yamada S, Ogawa Y, Nakata B, et al. RT-PCR detection of gastric cancer cells in sentinel lymph nodes. 4th International Gastric Cancer Congress, New York, April 29-May 2, 2001. Abstract # 383:430.
Bilchik AJ, Saha S, Tsioulias GJ, Wood TF, Morton DL. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Ann Surg Oncol 2001;9(Suppl):82S–85S.
Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Yamada T, Murata K, et al. Is sentinel node biopsy feasible for T 1–2 gastric cancer? 4th International Gastric Cancer Congress, New York, April 29–May 2, 2001. Abstract # 006:29.
Ishizaki M, Kurita A, Kubo Y, Takashima S, Nishina T, Nishimura E. Evaluation of sentinel node identification with isosulfan blue in gastric cancer. Eur J Surg Oncol 2006;32:191–196.
Sobin LH, Wittekind C. TNM classification of malignant tumors. 6th ed. New York: John Wiley & Sons; 2002.
Kodama Y, Sugimachi K, Soejima K, Matsusaka T, Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981;5:241–248.
Ichikura T, Chochi K, Sugasawa H, Yaguchi Y, Sakamoto N, Takahata R, et al. Individualized surgery for early gastric cancer guided by sentinel node biopsy. Surgery 2006;139:501–507.
McCulloch P, Nita ME, Kazi H, Gama-Rodriges J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004;4:CD001964.
Aikou T, Kitagawa Y, Kitajima M, Uenosono Y, Bilchik AJ, Martinez SR, et al. Sentinel lymph node mapping with GI cancer. Cancer Metastasis Rev 2006;25:269–277.
Iddings DM, Bilchik A. Gastric carcinoma: applying the sentinel node paradigm to improve the understanding of metastatic patterns and the possible role of selective lymphadenectomy. Ann Surg Oncol 2007;14:2432–2434.
Gipponi M. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms. Minerva Chir 2005;60:217–233.
Lee JH, Ryu KW, Kim CG, Kim SK, Lee JS, Kook MC, et al. Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol 2006;13:1168–1174.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rabin, I., Chikman, B., Lavy, R. et al. The accuracy of sentinel node mapping according to T stage in patients with gastric cancer. Gastric Cancer 13, 30–35 (2010). https://doi.org/10.1007/s10120-009-0532-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10120-009-0532-9